Search results
From Self-sufficiency
- ...ed Name|BAN]]) is a common [[local anesthetic]] and [[antiarrhythmic agent|antiarrhythmic]] drug. Lidocaine is used [[topical]]ly to relieve itching, burning and pai Lidocaine is also the most important class 1B antiarrhythmic drug: it is used intravenously for the treatment of [[ventricular arrhythmi15 KB (2,006 words) - 15:41, 27 September 2010
- It is sometimes considered a [[Antiarrhythmic_agent#Class_I_agents|class 1b antiarrhythmic]].<ref name="pmid15331289">{{cite journal |author=Balaji S |title=Medical t ...ct of a search among nonsedative structural relatives of phenobarbital for agents capable of suppressing electroshock convulsions in laboratory animals.''<re12 KB (1,686 words) - 15:42, 27 September 2010
- ...inflammatory medicines, medicines used to treat gout and disease modifying agents in rheumatoid disorders== ===Disease modifying agents used in rheumatoid disorders (DMARDs)===16 KB (1,353 words) - 20:21, 3 October 2011
- {{Antiarrhythmic agents}} [[Category:Inotropic agents]]19 KB (2,738 words) - 15:48, 27 September 2010
- *Magnesium sulfate is the first-line antiarrhythmic agent for [[torsades de pointes]] in [[cardiac arrest]] under the 2005 ECC *As a [[bronchodilator]] after beta-agonist and [[anticholinergic]] agents have been tried, e.g. in severe exacerbations of [[asthma]].<ref name=blitz14 KB (1,882 words) - 15:50, 27 September 2010
- ...increase cardiac contractility (it is a positive [[inotrope]]) and as an [[antiarrhythmic agent]] to control the heart rate, particularly in the irregular (and often [[Category:Antiarrhythmic agents]]15 KB (2,220 words) - 11:27, 7 July 2010
- * [[Antiarrhythmic agents]]8 KB (1,240 words) - 08:45, 20 September 2010
- '''Prajmaline''' is a class 1a [[antiarrhythmic agent]]. {{Antiarrhythmic agents}}1,023 bytes (115 words) - 08:43, 20 September 2010
- ...'''Pronestyl''', '''Procan''', '''Procanbid''') is a [[pharmaceutical]] [[antiarrhythmic agent]] used for the [[medicine|medical]] [[Pharmacotherapy|treatment]] of ...ide]] (NAPA), which is approximately equipotent with the parent drug as an antiarrhythmic agent<ref>Dutcher JS, Strong JM, Lucas SV, Lee WK, Atkinson AJ Jr. Procaina5 KB (586 words) - 08:43, 20 September 2010
- ...n_Williams_antiarrhythmic_classification|Vaughn Williams classification of antiarrhythmic drugs]]. {{Antiarrhythmic agents}}7 KB (891 words) - 08:44, 20 September 2010
- ...il''' (planned trade name '''Pulzium''') is an investigational class III [[antiarrhythmic]] for [[atrial fibrillation]] and atrial flutter. It is currently being de {{Antiarrhythmic agents}}2 KB (270 words) - 08:44, 20 September 2010
- '''Tocainide''' (Tonocard) is a class Ib [[antiarrhythmic agent]]. It is no longer sold in the United States. {{Antiarrhythmic agents}}2 KB (269 words) - 08:44, 20 September 2010
- ...31''' is an experimental [[Antiarrhythmic agent#Class III agents|class III antiarrhythmic drug ]] that blocks [[potassium channel]]s of the [[HERG|hERG-type]].<ref>K ...sulfonanilides as potent, selective, bioavailable class III antiarrhythmic agents. ''J Med Chem'' '''33''', 3, 903</ref>6 KB (859 words) - 08:45, 20 September 2010
- '''Potassium channel blockers''' are agents which interfere with conduction through [[potassium channel]]s. [[Image:Action potential Class III.png|thumb|275px|Effect of class III antiarrhythmic agent on cardiac action potential.]]5 KB (725 words) - 08:45, 20 September 2010
- '''Sodium channel blockers''' are [[Allosteric regulation#Pharmacology|agents]] that impair conduction of [[sodium]] ions (Na<sup>+</sup>) through [[sodi * [[Antiarrhythmic agent#Class I agents|Class I antiarrhythmic agents]]8 KB (1,123 words) - 08:45, 20 September 2010
- [[Category:Antiarrhythmic agents]]2 KB (228 words) - 20:28, 21 September 2010
- [[Category:Antiarrhythmic agents]]2 KB (284 words) - 20:29, 21 September 2010